Adt

Chapters 00:00 Introduction 00:23 Hormone Therapy and Sexual Function 04:06 Penile Shrinkage During Hormone Therapy 05:12 Cialis and Viagra During ADT 05:31 When to Start Cialis or Viagra 05:51 Is It Too Late to Restore Erectile Function? 06:34 When Cialis or Viagra Aren't Enough 07:25 What If...

In this eye-opening episode of the Dr. Geo Prostate Podcast, Dr. Geo sits down with world-renowned exercise oncology researcher Professor Robert Newton, founder of the Exercise Medicine Research Institute and one of the leading voices in cancer exercise science. Discover why exercise is now...

* Dr. Tombal recommends relugolix, an oral GnRH antagonist that restores normal testosterone within 90 to 120 days, when ADT is required, and notes that patients who fail to recover normal testosterone have worse prognosis. * He also supports testosterone supplementation in symptomatic...

* No one on the planet has published more in the area of exercise and prostate cancer on the planet than Dr. Newton and Dr. Newtons team in Australia Exercise oncology is the research and clinical application to people with cancer

* Currently, no clear guidelines exist, leaving clinicians to rely on incomplete but available clinical evidence. Although TST may be necessary in cases, such as successful PCa treatment or active surveillance for low-risk disease, extreme caution is advised for patients with moderate- or...

Androgen Deprivation Therapy (ADT) is commonly used in prostate cancer treatment, but it can have significant effects on sexual function. In this video from the ISSM and Movember, Dr. John Mulhall interviews Dr. Stacy Elliott about how testosterone influences sexual health, the consequences of...

Congratulations to Dr. Thomas Ahlering and Dr. David Lee, both included on Newsweek and Statista's AMERICA'S BEST PROSTATE CANCER SPECIALISTS award list. To spotlight the country's top prostate cancer specialists, Newsweek partnered with Statista for the first annual ranking of America's Best...

"What is the role of androgen deprivation therapy (ADT) in prostate cancer treatment? In this episode of the BackTable Urology Podcast, Dr. Rana McKay, a medical oncologist from UC San Diego, joins host Dr. Aditya Bagrodia to discuss the administration of ADT and other management strategies for...

Chapters: 0:34 What is testosterone replacement therapy (TRT)? 2:29 What is the dosing? 2:50 Explain adding testosterone when you are on ADT? 4:43 What is a normal testosterone level and one for someone on ADT? 7:10 How does quality of life and testosterone level relate? 7:55 Does...

As part of the 2024 Prostate Cancer Patient Conference, Dr. Eric Small reviews Androgen Deprivation Therapy, including choices of agents, side effects, considerations in timing, duration, intensity of therapy, and discusses interpretation of clinical trial results.

Background and purpose To determine the rate and time of testosterone (T) recovery in patients (pts) with localised prostate cancer treated with radiotherapy plus 0-, 6-, 18- or 36-month of androgen deprivation therapy (ADT).Materials and methods In 1230 pts with prostate cancer randomised into...

BACKGROUND Prostate cancer is a prevalent disease that urgently needs to address its treatment-related complications. By examining existing evidence on the association between Androgen Deprivation Therapy (ADT) and dementia, this study contributes to the understanding of potential risks. We...

Today, we're joined by Charles Hilson, a patient advocate and penile rehabilitation expert who embarked on a journey to restore his intimate life after prostate cancer surgery. Frustrated by the lack of information, Charles now dedicates himself to educating others about penile health. Charles...

Prostate Cancer treatments cause penises to shorten. Dr. Kohler explains why and what if anything can be done to restore its length. Tobias S. Kohler, M.D., M.P.H., is a urologist, with a specialty in erectile dysfunction. Dr. Kohler is a physician trainer for penile prosthesis surgery in the...

Cancer treatments damage men's ability to enjoy sex. Dr. Kohler talks about ways you and your urologist can restore your sexual functioning and enjoyment. Tobias S. Kohler, M.D., M.P.H., is a urologist, with a specialty in erectile dysfunction. Dr. Kohler is a physician trainer for penile...

https://www.onclive.com/view/trt-in-patients-with-prostate-cancer-on-active-surveillance-are-we-really-putting-gas-on-fire- Investigators hypothesized that testosterone replacement does not have a negative impact on the oncologic outcomes of treatment-naive patients with prostate cancer on...

The video presented a treatment called Bipolar Androgen Therapy (BAT) for prostate cancer, in which patients are given high doses of testosterone to resensitize the cancer to hormone therapy. Dr. Sam Denme discussed the concept, results from trials, and future research, highlighting the...

Dr. Mulhall is very thorough and on point as usual! In this video, Dr. John Mulhall discusses the impact of prostate cancer treatment on sexual health. He emphasizes the importance of fully informed consent and realistic expectations before treatment. He explains the common sexual...

In this video, Dr. Richard Roehr and Dr. Lauren Walker discuss the challenges and side effects of Androgen Deprivation Therapy (ADT), also known as hormone therapy, for prostate cancer patients. They highlight the psychological and physical side effects, including loss of sex drive, fatigue, hot...

Loved this one! True Warrior! “If we continue to do the same things, we will get the same results.” “If BAT can be used to sensitive Xtandi/darolutamide ad infinitum, prostate cancer becomes a treatable condition like diabetes.” – Russ Hollyer Meeting Summary Advanced prostate...

https://www.urotoday.com/video-lectures/pcf-2022/video/2959-bipolar-androgen-therapy-in-the-management-of-prostate-cancer-samuel-denmeade.html Samuel Denmeade, Co-Director of the Johns Hopkins Prostate Cancer Program joins Alicia Morgans in a discussion on Bipolar Androgen Therapy (BAT) for...

The review discusses the growing concern about cardiovascular complications arising from androgen deprivation therapy (ADT) for prostate cancer patients. These complications are not solely due to androgen suppression, as specific types of ADT lead to distinct cardiovascular issues. The purpose...

https://music.amazon.ca/fr-ca/podcasts/3deef1ea-2731-48be-998b-7afc38ee8702/prostate-cancer-clinical-masterclass-series Welcome to The Prostate Cancer Clinical Masterclass Series which is co-chaired by Dr Sumit Subudhi and Dr Gerhardt Attard. This is a twelve-month initiative, consisting of...

Medical Oncologist Mark Scholz, MD gives a survey of testosterone replacement therapy (TRT) in the context of prostate cancer. Historically, some in the medical community have been hesitant to consider testosterone in patients with a history of prostate cancer out of fear of exacerbating the...

Join us for a compassionate and insightful discussion about the impact of prostate cancer on sexual health and the available options for rehabilitation. This video offers a focus on evidence-based practices and real-world solutions. From the physical to the emotional, this panel covers the full...

Carolyn Salter, MD from Memorial Sloan Kettering Cancer Center, gives a patient-focused presentation about Androgen Deprivation Therapy, also known as "hormone therapy" for prostate cancer.

Urologist – Carolyn Salter, MD – Memorial Sloan Kettering Cancer Center *16:29-18:00 (testosterone therapy after prostate cancer) Prostate Cancer Patient Virtual Conference 2022 Presenters: Medical Oncologist – Karen Autio, MD – Memorial Sloan Kettering Cancer Center Epidemiologist –...

https://www.urotoday.com/video-lectures/asco-gu-2023/video/3299-testosterone-recovery-in-patients-with-prostate-cancer-treated-with-radiotherapy-plus-adt-tanya-dorff.html Tanya Dorff and Alicia Morgans discuss testosterone suppression and recovery in prostate cancer patients. They review data...

In a program supported by Verity Pharmaceuticals, E. David Crawford, MD, Editor-in-Chief of Grand Rounds in Urology and Professor of Urology at the University of California, San Diego; Neal D. Shore, MD, FACS, Medical Director for the Carolina Urologic Research Center; and Benjamin H...